Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Reporter Gene Assay Market Size Worth $9.0 Billion by 2027: Grand View Research, Inc.

This image opens in the lightbox

News provided by

Grand View Research, Inc.

01 Jun, 2020, 08:35 GMT

Share this article

Share toX

Share this article

Share toX

SAN FRANCISCO, June 1, 2020 /PRNewswire/ --The global reporter gene assay market size is expected to reach USD 9.0 billion by 2027 registering a CAGR of 8.1%, according to a new report by Grand View Research, Inc. Reporter genes have significant demand as they are increasingly being used in studying gene expression and across several research studies in the fields of biochemistry, molecular biology, and pharmaceuticals. Reporter genes also play a pivotal role in quantifying the regulatory potential of unknown DNA sequences.

Key suggestions from the report:

  • Luciferase assays accounted for the highest revenue share in 2019 and is anticipated to retain its leading position throughout the forecast period
  • This is because luciferase enables precise measurement of signal maintaining consistency of the outcomes
  • In vitro studies application segment is projected to register the fastest CAGR of 8.3% from 2020 to 2027 owing to increasing need for rapid screening
  • Cell signaling pathways subsegment displayed the highest contribution to the clinical applications segment in 2019 owing to rise in adoption of reporter assays for GPCR signaling investigations and for screening chemicals that cause signaling disruption
  • These protocols are majorly employed in drug discovery programs, which has largely contributed to the growth of this segment in the global market throughout the forecast period
  • Hospital & diagnostic laboratories end-use segment is expected to register the highest CAGR from 2020 to 2027
  • North America accounted for the highest revenue share in 2019 owing to high penetration of cell-based assay technologies in the regional market
  • Asia Pacific is expected to witness the fastest CAGR from 2020 to 2027 due to rise in the number of research investigations that are focused on use of reporter genes for regulation of several disorders

Read 152 page research report with ToC on "Reporter Gene Assay Market Size, Share & Trends Analysis Report By Application (In Vitro Studies, Clinical), By Product (Luciferase, Beta-galactosidase), By Usage, By End Use, And Segment Forecasts, 2020 - 2027" at: https://www.grandviewresearch.com/industry-analysis/reporter-gene-assay-market

Rising penetration of these assays in diagnostic applications and their utility in understanding signal transduction pathways is expected to propel the market growth. Promega Corporation has developed vectors that can be used in investigation of signaling pathways. The company has also developed rapid response reporters to enhance the signal to background ratio.

Several other prominent market players also offer a strong product portfolio for luciferase assays. For instance, ThermoFisher Scientific offers a wide range of luciferase and Chemiluminescent assays to monitor the reporter activity. Moreover, presence of key market players such as Promega Corporation in developing economies is expected to drive the demand in this market.

Grand View Research has segmented the global reporter gene assay market on the basis of product, application, usage, end use, and region:

  • Reporter Gene Assay Product Outlook (Revenue, USD Million, 2016 - 2027)
    • Luciferase
    • Fluorescent Protein-related
    • Chloramphenicol Acetyltransferase
    • Beta-Galactosidase
    • Beta-Glucuronidase
    • Others
  • Reporter Gene Assay Application Outlook (Revenue, USD Million, 2016 - 2027)
    • Clinical Applications
      • Cell Signaling Pathways
      • Promoter Structural and Functional Analysis
      • Protein Interaction
    • In-vitro Studies
  • Reporter Gene Assay Usage Outlook (Revenue, USD Million, 2016 - 2027)
    • Drug Discovery Programs
    • Chemical Biology Programs
    • Biochemical Screening
    • Cell- & Organ-based Screening
  • Reporter Gene Assay End-use Outlook (Revenue, USD Million, 2016 - 2027)
    • Hospital & Diagnostic Laboratories
    • Academic & Research Institutes
    • Contract Research Organizations (CROs)
    • Pharmaceutical & Biotechnology Companies
  • Reporter Gene Assay Regional Outlook (Revenue, USD Million, 2016 - 2027)
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
    • Asia Pacific
      • China
      • Japan
      • India
      • Australia
    • Latin America
      • Brazil
      • Mexico
    • MEA
      • South Africa
      • Saudi Arabia
  • List of Key Companies of Reporter Gene Assay Market
    • QIAGEN
    • Thermo Fisher Scientific
    • Sartorius AG
    • Berthold Technologies GmbH & Co. KG
    • Promega Corp.
    • Marker Gene Technologies, Inc.
    • Merck KGaA
    • F. Hoffmann-La Roche AG
    • PerkinElmer Life Science
    • Bio-Rad Laboratories

Find more research reports on Biotechnology Industry, by Grand View Research:

  • CRISPR & Cas Genes Market – Global clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) genes market size was valued at USD 1.42 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 16.6% from 2020 to 2027.
  • Gene Therapy Market – Global gene therapy market size was estimated at USD 1.2 billion in 2019 and is projected to register a CAGR 16.6% over the forecast period.
  • DNA & Gene Chip Market – Global DNA & gene chip market size was valued at USD 4.50 billion in 2017 and is projected to exhibit a CAGR of 11.4% during the forecast period.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: +1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com  
Follow Us: LinkedIn | Twitter

Modal title

Also from this source

AI in Diagnostics Market to Reach USD 9.7 Billion by 2033, Driven by Rising Demand for Faster and More Accurate Disease Detection

AI in Diagnostics Market to Reach USD 9.7 Billion by 2033, Driven by Rising Demand for Faster and More Accurate Disease Detection

The global artificial intelligence in diagnostics market size is expected to reach USD 9.68 billion by 2033, registering a compound annual growth...

Digital Health Market Size to Reach USD 1,830.4 Billion by 2033, Driven by Rising Adoption of Telehealth, mHealth, AI-Based Solutions, and Connected Healthcare Technologies: Grand View Research, Inc.

Digital Health Market Size to Reach USD 1,830.4 Billion by 2033, Driven by Rising Adoption of Telehealth, mHealth, AI-Based Solutions, and Connected Healthcare Technologies: Grand View Research, Inc.

The global digital health market is expected to witness significant expansion over the coming years, with the market size estimated at USD 347.4...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Biotechnology

Biotechnology

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.